Andlauer Healthcare Group Inc.
AND.TO
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.74% | -0.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.74% | -0.82% | |||
| Cost of Revenue | 3.16% | -1.94% | |||
| Gross Profit | 1.93% | 1.41% | |||
| SG&A Expenses | -7.37% | -5.44% | |||
| Depreciation & Amortization | -1.16% | -0.99% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.57% | -2.18% | |||
| Operating Income | 9.44% | 7.70% | |||
| Income Before Tax | 5.50% | 3.99% | |||
| Income Tax Expenses | 7.24% | 4.33% | |||
| Earnings from Continuing Operations | 4.86% | 3.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.86% | 3.87% | |||
| EBIT | 9.44% | 7.70% | |||
| EBITDA | 30.01% | 46.34% | |||
| EPS Basic | 5.28% | 8.37% | |||
| Normalized Basic EPS | 5.91% | 8.51% | |||
| EPS Diluted | 4.99% | 8.25% | |||
| Normalized Diluted EPS | 6.03% | 8.68% | |||
| Average Basic Shares Outstanding | -0.37% | -4.18% | |||
| Average Diluted Shares Outstanding | -0.53% | -4.31% | |||
| Dividend Per Share | -2.60% | 10.40% | |||
| Payout Ratio | -0.07% | 0.06% | |||
